Digitalisation does not stop at the pharmaceutical industry. The use of new technologies opens up opportunities for process optimisation along the entire life cycle of pharmaceuticals and pharmaceutical products, from research into new active substances and therapies to production, packaging, distribution and application. However, digital innovation not only offers many opportunities, but also poses major challenges for the industry due to the strong regulation of drug production.
Because anyone who violates guidelines when developing drugs or medical devices not only puts a lot of money and his reputation at risk, but also the health of the patient. This makes it all the more important for companies to have access to reliable systems that support them in complying with legal requirements such as Good Automated Manufacturing Practice (GAMP).
